My company is an R&D and software as a medical service company based in the USA with over 50 patents. The company was founded over 10 years ago. We have only made sales of less than 100k.
10k sales/year is a hobby. Get a commissioned broker to sell the patents and find something else to do while he does it, before you lose even more time on this unproductive activity.
You should approach a group like Intellectual Ventures in Seattle. While many are discouraging you on the revenue number, medtech is valued very highly when there is traction and opportunity supported by solid IP. Adoption rate in the space is very slow, yet when it does adopt, it is voracious. Seattle has a significant medtech community that could find this interesting.
Andrew is right that at $100K total sales, you need to grow before you can reasonably expect to sell. The patent portfolio can be monetized in a variety of ways as well. I would consider growth as an approach, and you can read the free content at http://a2e.co/ to help grow your company. Beyond that you probably need some help to execute on meeting your goals, and that takes time with experts.
What area of medical service you are providing?
Thanks for your input.
We will consider your suggestion.
Investors buy companies based on their return on investment. Returns come from either current profits, future profit potential, or the proceeds from the sales of the company's assets. Sales under $100k means returns from current profits are basically non-existent. The idea that sales are that low after ten years suggests that the profit potential of the company is minimal. That's probably why the first poster suggested selling the assets (the patents).
By the way, all an issued patent says is that the invention is novel. It doesn't mean that the practice of the invention and the underlying patent has value. What is the value today of a patent for a buggy whip or an analog communications system?
We provide Cardio Vascular Disease risk assessment using AI and machine learning. Or team has invested over $3m over the last 10 years. We have over 700 peer review publications . We have a proven concept. We are only considering full commercialization this year. We have a few hospitals and clinics in the United States, India and Nigeria as clients.
Thanks for your contribution an idea. We are yet engage in any commercialization efforts. Our focus over the years has been in R&D.
US hospital networks sometimes have embedded venture funds and incubators as part of their operations. Have you reached out to any with cardio initiatives?